HCMC – The Drug Administration of Vietnam has decided to suspend the licenses of three pharmaceutical companies for the import of pharmaceutical products and materials over quality violations, the local media reported.
The three companies are the HCMC Medical Import Export Joint Stock Company, the R.X. Manufacturing Company Limited from Thailand, and the Zuellig Pharma Vietnam Limited.
The HCMC Medical Import Export JSC has had its import license suspended until further notice because it imported 11 batches of Myomethol for treating acute osteoarthritis pain that violate quality standards.
Similarly, R.X. Manufacturing Co., Ltd. has been banned from importing all drugs and drug materials as the company produced and supplied the 11 batches of Myomethol mentioned above. The suspension is valid for one year, starting April 7, 2023.
In addition, the Drug Administration fined the company VND80 million and forced it to destroy all drugs that failed to meet quality standards in late March 2023.
The application for a drug import license from the branch of Zuellig Pharma Vietnam has also been suspended, as it previously bought two batches of Zinnat Suspension and two batches of Neurobion that violated quality standards. The duration of the suspension will be announced later.
The agency had revoked the registration certificate for the circulation of Zinnat Suspension antibiotics in Vietnam due to the quality violation.
